IPO Outlook For The Week: Fintech, Analytics And Respiratory Medtech

For a more comprehensive IPO calendar, check out the offering in Benzinga Cloud. The IPO dates below are expected, but not confirmed.

Vapotherm Inc (VAPO) will issue 4 million shares between $14 and $16 Wednesday on the New York Stock Exchange. The medtech firm markets Hi-VNI Technology — an alternative to intubation and mechanical ventilation for patients experiencing respiratory distress.

Centrexion Therapeutics Corp (CNTX) will issue 5 million shares between $14 and $16 Thursday on the Nasdaq. Based in Boston, the biotech company develops non-opioid treatments for chronic pain.

Qualtrics International Inc. (XM) will issue more than 20.5 million shares between $18 and $21 Thursday on the Nasdaq. The business analytics platform supports more than 9,000 brands in nine countries.

Weidai Ltd. (WEI) will issue 4.5 million shares between $9 and $11 Thursday on the New York Stock Exchange. Launched in 2011, the online financial firm facilitates micro-lending for auto financing in China.

Fintech Acquisition Corp. III (FTACU) will issue 27.5 million shares at $10 Friday on the Nasdaq. The blank-check company targets businesses in financial technology focusing on data processing, databases, payment processing services, and storage and transmission services.

To learn more about other companies in the space, check out the Benzinga Fintech Summit, a gathering of the top leaders in payments, lending, capital markets, blockchain and cryptocurrencies in San Francisco Nov. 14.

Related Links:

5 Reasons Why 2018 Could Be Good For IPO ETFs

3 Tech IPOs We Want In 2018

Posted In: NewsPreviewsIPOsTrading Ideas
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...